Table 1. Serum concentrations of KLK6 and S100B (ng/mL) in the initial sample and all samples collected within the first 56 hours from patients with subarachnoid hemorrhage.

PatientNo.	KLK6(initial)	FC*	KLK6(56 hours)†	FC*	S100B (initial)	S100B(56 hours)†	Outcome§
1	1.46	+1.4	0.78±0.40	−1.3			GR
7	1.54	+1.5	1.10±0.30	+1.1			GR
9	1.22	+1.2	0.96±0.23	−1.1	0.08	0.07±0.02	GR
11	1.05	+1.0	1.25±0.34	+1.2			GR
13	1.72	+1.7	1.40±0.52	+1.3			GR
3	1.02	+1.0	0.69±0.24	−1.5	0.05	0.05±0.01	MD
6	0.73	−1.4	0.66±0.24	−1.6	0.22	0.45±0.18	MD
10	2.17	+2.1	1.44±0.62	+1.4			MD
8	0.54	−1.9	0.49±0.08	−2.1	0.01	0.03±0.01	SD
12	1.32	+1.3	0.87±0.43	−1.2	0.11	0.30±0.10	SD
2	0.54	−1.9	0.40±0.20	−2.6	0.04	0.09±0.04	D
4	0.23	−4.5	0.27±0.10	−3.9	0.38	0.37±0.11	D
5	0.30	−3.5	0.34±0.10	−3.1	0.06	0.33±0.24	D

^* FC: Fold change with respect to lower reference limit (1.04 ng/mL).

^†Values are expressed as mean ± standard deviation.

^§GR: Good recovery, MD: Moderate disability, SD: Severe disability, D: Death.